Nottingham City Hospital is a large hospital located in Nottingham, England. It occupies a large 90-acre site on the ring road to the North of the city centre. It is composed of many buildings, most of which are joined together by long corridors.

There are 1,100 beds in Nottingham City Hospital.

During the past decade, Nottingham City Hospital conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 39 clinical trials were completed, i.e. on average, 45.3% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 24 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nottingham City Hospital" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "University College, London" with 9 trials sponsored, "Celgene" with 7 trials sponsored, "University of Birmingham" with 6 trials sponsored and "Daiichi Sankyo, Inc." with 6 trials sponsored. Other sponsors include 137 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nottingham City Hospital" #1 collaborator was "Cancer Research UK" with 17 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator and "Pfizer" with 4 trials as a collaborator. Other collaborators include 115 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Nottingham City Hospital" are "Breast Cancer" (22 trials), "Prostate Cancer" (10 trials), "Multiple Myeloma" (5 trials), "Lung Cancer" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Nottingham City Hospital" in a lesser frequency.

Most popular intervention types in "Nottingham City Hospital" are "Drug" (138 trials), "Other" (32 trials), "Procedure" (22 trials), "Biological" (18 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "quality-of-life assessment" (9 trials), "Cyclophosphamide" (6 trials), "Docetaxel" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Nottingham City Hospital" are 152 trials for "All" genders, 17 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are 59 active trials in "Nottingham City Hospital". 1 are not yet recruiting, 28 are recruiting, 29 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 83 completed trials in Nottingham City Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Nottingham City Hospital, 6 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 15 trials that are defined as “Not Applicable".